Versican: a versatile extracellular matrix proteoglycan in cell biologyWight 621
2.Zimmermann D: Versican.In Proteoglycans-Structure, Biology and
Molecular Interactions. Edited by Iozzo R. New York: Marcel Dekker,Inc; 2000:327-341.
This is an excellent, concise summary of the structure and function of versican. There are excellent discussions on the gene and protein structureof versican and its importance in cell biology.3.Zimmermann DR, Ruoslahti E: Multiple domains of the largefibroblast proteoglycan, versican.EMBO J1989, 8:2975-2981.4.
Dours-Zimmermann MT, Zimmerman DR: A novel glycosaminoglycanattachment domain identified in two alternative splice variants ofhuman versican.J Biol Chem1994, 269:32992-32998.
5.
Ito K, Shinomura T, Zako M, Ujita M, Kimata K: Multiple forms ofmouse PG-M, a large chondroitin sulfate proteoglycan generatedby alternative splicing.J Biol Chem1995, 270:958-965.
6.
Schmalfeldt M, Dours-Zimmermann MT, Winterhalter KH, ZimmermannDR:Versican V2 is a major extracellular matrix component of the maturebovine brain.J Biol Chem1998, 273:15758-15764.
7.
Shinomura T, Nishida Y, Ito K, Kimata K: cDNA cloning of PG-M,alarge chondroitin sulfate proteoglycan expressed during
chondrogenesis in chick limb buds. Alternative spliced multiformsof PG-M and their relationship to versican.J Biol Chem1993,268:14461-14469.
8.
Yao LY, Moody C, Schönherr E, Wight TN, Sandell LJ: Identificationof the proteoglycan versican in aorta and smooth muscle cells byDNA sequence analysis, in situhybridization and
immunohistochemistry.Matrix Biol1994, 14:213-225.
9.
Stigson MKL: Molecular cloning of a PG-M/versican-like
proteoglycan of the axolotl embryo. In Large chondroitin sulfateproteoglycans in the axolotl embryo [PhD Thesis]. Uppsala, Sweden:Uppsala University; 1996.
10.Schönherr E, Järveläinen HT, Sandell LJ, Wight TN: Effects of
platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfateproteoglycan by arterial smooth muscle cells.J Biol Chem1991,266:17640-17647.11.Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K:
Regulation of cell-substrate adhesion by proteoglycansimmobilized on extracellular substrates.J Biol Chem1989,264:8012-8018.12.Yamagata M, Saga S, Kato M, Bernfield M, Kimata K: Selective
distributions of proteoglycans and their ligands in pericellularmatrix of cultured fibroblasts. Implications for their roles incell–substratum adhesion.J Cell Sci1993, 106:55-65.13.Yamagata M, Kimata K: Repression of a malignant cell-substratum
adhesion phenotype by inhibiting the production of the anti-adhesiveproteoglycan, PG-M/versican.J Cell Sci1994, 107:2581-2590.14.Ang LC, Zhang Y, Cao L, Yang BL, Young B, Kiani C, Lee V, Allan K,
Yang BB: Versican enhances locomotion of astrocytoma cells andreduces cell adhesion through its G1 domain.J Neuropathol ExpNeurol1999, 58:597-605.15.Yang BL, Zhang Y, Cao L, Yang BB: Cell adhesion and proliferation
mediated through the G1 domain of versican.J Cell Biochem1999, 72:210-220.16.Wu Y, Chen L, Zheng PS, Yang BB: Beta 1-integrin-mediated glioma cell adhesion and free-radical-induced apoptosis are
regulated by binding to a C-terminal domain of PG-M/versican.JBiol Chem2002, 277:12294-12231.
Another seminal paper from the Yang group. This study is the first to showthat versican interacts with the β1integrin and signals through integrin-mediated responses. This not only affects cell adhesion, but also cell survival. These studies may have uncovered a whole new world for proteo-glycans in regulating cell phenotype.17.
Kawashima H, Li YF, Watanabe N, Hirose J, Hirose M, Miyasaka M:Identification and characterization of ligands for L-selectin in thekidney. I. Versican, a large chondroitin sulfate proteoglycan, is aligand for L-selectin.Int Immunol1999, 11:393-405.
18.Kawashima H, Hirose M, Hirose J, Nagakubo D, Plaas AH, MiyasakaM: Binding of a large chondroitin sulfate/dermatan
sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.J Biol Chem2000, 275:35448-35456.
This is a nice study showing that versican interacts with a series of cytokines toinfluence specific aspects of the inflammatory response. It is a key paper sup-porting a role for versican as an extracellular matrix component in inflammation.
19.Kawashima H, Atarashi K, Hirose M, Hirose J, Yamada S, Sugahara K, Miyasaka M: Oversulfated chondroitin/dermatan sulfates
containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate)
interact with L- and P-selectin and chemokines.J Biol Chem2002,277:12921-12930.
This paper describes a key discovery: it is but one of a few attempts todefine the sequence of disaccharides in versican responsible for cytokinebinding. It provides good evidence that the carbohydrate moiety of versicanmay exhibit the pro-inflammatory activity.
20.Bajorath J, Greenfield B, Munro SB, Day AJ, Aruffo A: Identification
of CD44 residues important for hyaluronan binding and
delineation of the binding site.J Biol Chem1998, 273:338-343.21.Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M: Versican interacts with chemokines and modulates cellular responses.
JBiol Chem2001, 276:5228-5234.
An important paper that shows that versican binding to SLC (secondary lymphoid-tissue chemokine) inhibits αintracellular Ca2+response. One of only a few studies to date that shows4β7integrin activation as well as theversican affecting the activity of a growth factor or chemokine.
22.Schönherr E, Kinsella MG, Wight TN: Genistein selectively inhibits
platelet-derived growth factor stimulated versican biosynthesis inmonkey arterial smooth muscle cells.Arch Biochem Biophys1997,339:353-361.23.Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN: Platelet-derived growth factor stimulates the formation of
versican-hyaluronan aggregates and pericellular matrix
expansion in arterial smooth muscle cells.Arch Biochem Biophys2001, 394:29-38.
This study combines videomicroscopy, biochemistry and RT-PCR analysis toimplicate complexes of hyaluronan and versican in controlling cell prolifera-tion and migration. The observations support a role for versican, but they arecorrelative. More direct evidence of involvement, using knockout systems,will be needed in the future.
24.Evanko SP, Angello JC, Wight TN: Formation of hyaluronan and
versican-rich pericellular matrix is required for proliferation andmigration of vascular smooth muscle cells.Arterioscler ThrombVasc Biol1999, 19:1004-1013.25.Isogai Z, Shinomura T, Yamakawa N, Takeuchi J, Tsuji T, Heinegard D,
Kimata K: 2B1 antigen characteristically expressed on
extracellular matrices of human malignant tumors is a largechondroitin sulfate proteoglycan, PG-M/versican.Cancer Res1996, 56:3902-3908.26.Nara Y, Kato Y, Torii Y, Tsuji Y, Nakagaki S, Goto S, Isobe H,
Nakashima N, Takeuchi J: Immunohistochemical localization ofextracellular matrix components in human breast tumours withspecial reference to PG-M/versican.Histochem J1997, 29:21-30.27.
Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML,YeoTK, Tognazzi K, Dvorak HF: Vascular stroma formation in
carcinoma in situ, invasive carcinoma, and metastatic carcinomaof the breast.Clin Cancer Res1999, 5:1041-1056.
28.Ricciardelli C, Brooks JH, Suwiwat S, Sakko AJ, Mayne K, RaymondWA, Seshadri R, LeBaron RG, Horsfall DJ: Regulation of
stromal versican expression by breast cancer cells and
importance to relapse-free survival in patients with node-negativeprimary breast cancer.Clin Cancer Res2002, 8:1054-1060.
The authors attempt to use versican synthesis by mammary fibroblasts as aprognostic indicator of relapse-free survival of breast cancer patients. This isan interesting attempt to use this extracellular molecule as a diagnostic tool.Positive results are encouraging, but more quantitative data are needed.29.Paulus W, Baur I, Dours-Zimmerman MT, Zimmermann DR:
Differential expression of versican isoforms in brain tumors.JNeuropathol Exp Neurol1996, 55:528-533. 30.Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG, HorsfallDJ: Versican accumulation in human prostatic fibroblast
cultures is enhanced by prostate cancer cell-derived transforminggrowth factor beta1. Cancer Res2001, 61:926-930.
This is an interesting study that uses clinical samples to explore the reasonswhy versican accumulates in the stroma of prostate cancer. These versicanchanges seem to be common to many cancers and the challenge will be to determine whether they are causative or secondary to some other primary event.
31.Ricciardelli C, Mayne K, Sykes PJ, Raymond WA, McCaul K,
MarshallVR, Horsfall DJ: Elevated levels of versican but notdEcoRIn predict disease progression in early-stage prostatecancer.Clin Cancer Res1998, 4:963-971.
the extracellular matrix genes, and the cell ...proteoglycan-II, glypican, and a Miscellaneous DNA...Biology of polycystic kidney disease. Lab Invest ...
this versatile kinase also enhances the activity ...[19]; the extracellular matrix protein cartilage ...a predominate role for cAMP in granulosa cell ...
Corresponding author: Jody A. Rada, Department of Anatomy and Cell Biology,...Signi?cant changes in scleral extracellular matrix synthesis, accumulation, and...
and Chris Sander Computational Biology Center, ...in a highly versatile signalprocessing unit, able...cell migration, adhesion and extracellular matrix ...
and Chris Sander Computational Biology Center, ...in a highly versatile signalprocessing unit, able...cell migration, adhesion and extracellular matrix ...
热门文档